Search

A recent study conducted by researchers at Zhejiang University School of Medicine examined the global status of antimicrobial resistance in clinical Enterococcus faecalis isolates. The study found that antibiotic resistance in E. faecalis is increasing worldwide, making it a potentially opportunistic pathogen that can cause various healthcare-associated and life-threatening diseases. The researchers analyzed data from 74 studies conducted in 28 countries and identified significant differences in antibiotic resistance rates across different countries. They also suggested that preventive strategies used in Europe and Australia, where antibiotic resistance is relatively low, could be effective in other regions with high resistance rates. The study concluded that daptomycin and tigecycline could be effective treatments for E. faecalis infections. [Extracted from the article]

A study conducted by researchers at Yunnan Agricultural University in Kunming, China, has found that the gut symbiont Enterococcus mundtii plays a central role in the resistance of the tomato leaf miner (Tuta absoluta) to the pesticide chlorantraniliprole (CAP). The researchers isolated seven strains of CAP-tolerant bacteria from the gut of CAP-resistant T. absoluta, with E. mundtii E14 showing the highest tolerance. Through transcriptomics and metabolism analysis, they discovered that E. mundtii E14 can degrade CAP into non-toxic compounds. The study provides new insights into T. absoluta resistance to CAP and highlights the importance of gut symbionts in pest management. [Extracted from the article]

Researchers at the Department of Biotechnologies in Gujarat, India have published a comprehensive review on the exploration and synthesis of bioactive compounds by Enterococcus species. The review discusses the taxonomy, natural habitat, and significance of Enterococcus in biotechnology, as well as the various bioactive compounds it produces, including antibacterial, immunomodulatory, and antioxidant agents. The article also covers strategies for exploring potential bioactivities, fermentation processes for synthesizing bioactive compounds, and the utilization of these compounds in functional foods, pharmaceuticals, and agriculture. The review concludes with future perspectives and challenges in the field of Enterococcus-derived bioactive compounds. [Extracted from the article]

A recent study conducted by researchers at Islamic Azad University focused on the removal of the antibiotic ciprofloxacin from aqueous solutions using a Photo-Fenton like (PFL) process and CuCOFe2O4@AC (CAC) magnetic nanoparticles as catalysts. The study found that the PFL process was the most effective, achieving a removal efficiency of 95.99%. The research also concluded that the treated wastewater samples were non-toxic to E. coli and E. faecalis bacteria, suggesting that this technique could be used for pharmaceutical industry wastewater treatment. The full study can be accessed through the Applied Water Science journal. [Extracted from the article]

A recent study from McMaster University explores the rising prevalence of multidrug-resistant bacterial infections and the limited development of antibiotics to combat them. The researchers focused on enterococci, a major contributor to this crisis, and investigated the potential use of bacteriophage therapy, which utilizes lytic viruses to kill pathogenic bacteria. Through their research, they identified a genetic locus involved in phage resistance and discovered a protein that inhibits type IV restriction enzymes, which are involved in antiphage defense. These findings provide insight into phage defense mechanisms and how phages evolve to overcome antiphage defense systems. [Extracted from the article]

A study conducted at Gachon University in South Korea analyzed blood culture data from 2016 to 2020 to determine the distribution of bacteria and antibiotic resistance patterns. The most commonly isolated bacterium from blood cultures was Escherichia coli, followed by Klebsiella pneumoniae and Staphylococcus aureus. The study found that the resistance rates of certain antibiotics, such as ciprofloxacin and imipenem, increased over the study period for some bacteria. The research highlights the importance of consistently collecting and analyzing blood culture results to inform antibiotic treatment decisions. [Extracted from the article]

A recent study conducted by researchers at Shiraz University of Medical Sciences in Iran has focused on the emergence of antibiotic resistance in hospital-acquired infections, specifically Vancomycin-Resistant Enterococci (VRE). The study highlights the importance of identifying transmission routes and implementing proper hygiene practices to prevent the spread of VRE among patients. The researchers discuss a case study involving a 2.5-year-old boy with End-Stage Renal Disease (ESRD) and Focal Segmental Glomerulosclerosis (FSGS) who developed a vancomycin-resistant enterococci infection during his hospital stay. The infection was successfully treated with linezolid antibiotics. This research emphasizes the need for healthcare workers to be aware of transmission routes and to practice appropriate hygiene and care procedures in medical centers. [Extracted from the article]

A study conducted at the University of Patras in Greece has investigated the use of thermally treated palygorskite (TP) as an adsorbent to remove Escherichia coli and Enterococcus faecalis from synthetic wastewater. The goal of the research is to find a natural alternative to chlorine-based disinfectants by utilizing TP's antimicrobial properties. The study found that the multilayer arrangement of TP achieved the highest bacterial removal efficiency, reaching 99.1% for E. coli and 98.1% for E. faecalis. The research suggests that TP has significant potential as an adsorbent for wastewater disinfection and further research should focus on scaling this method to real-world conditions. [Extracted from the article]

A recent study conducted by Soonchunhyang University in South Korea has found that totarol, a natural compound derived from Podocarpus totara, exhibits potent antibacterial effects against vancomycin-resistant Enterococcus faecalis (VREF). The study showed that totarol not only inhibits biofilm formation but also reduces the viability of bacterial cells. Additionally, when used in combination with vancomycin, totarol demonstrated antibacterial activity. However, since this was an in vitro study, further research is needed to determine the clinical implications of totarol in the treatment of VREF. [Extracted from the article]

Researchers at Universidade Federal de Campina Grande have conducted a study on the antibacterial effects of (R)-(+)-limonene against Enterococcus faecalis and Enterobacter cloacae strains. The study found that (R)-(+)-limonene exhibited moderate bactericidal effects against E. faecalis strains, but had no antibacterial effect against E. cloacae strains. However, when combined with certain synthetic antimicrobials, (R)-(+)-limonene showed synergistic effects against most strains. The researchers suggest that (R)-(+)-limonene holds promise for enhancing the treatment of bacterial infections, but further studies are needed to confirm its efficacy and mechanisms. [Extracted from the article]

Researchers at the Mayo Clinic in Rochester, Minnesota have conducted a study comparing two high-throughput liquid-based assays for testing the susceptibility of phages (viruses that infect bacteria) against bacterial isolates. Phage therapy is a promising strategy for treating drug-resistant bacterial infections, but not all phages are effective against all strains of bacteria. The study found that both assays provided good statistical reproducibility for assessing phage susceptibility, with high agreement between the two methods for non-susceptible isolates. This research contributes to the development of standardized and clinically validated methods for testing the activity of phages against bacterial infections. [Extracted from the article]

A preprint abstract from biorxiv.org discusses the potential of two natural ribosomally-synthesized lasso peptides, sviceucin and siamycin I, as new drugs to combat antibiotic resistance. The peptides were found to inhibit the histidine kinases FsrC and VanS, which control bacterial virulence and vancomycin resistance in enterococci and Staphylococcus aureus. The peptides were effective in restoring vancomycin susceptibility in vitro and in a surrogate animal model, and strains resistant to the vancomycin/peptide combination were still susceptible to the peptides' anti-virulence effect. This research suggests that these lasso peptides could be promising candidates for the development of next-generation antibiotics. However, it is important to note that this preprint has not yet undergone peer review. [Extracted from the article]

Researchers from Chiang Mai University in Thailand have conducted a study on the antibacterial and antibiofilm activities of aqueous crude Gymnema inodorum leaf extract (GIE) against vancomycin-resistant Enterococcus faecium (VREF). The study found that GIE exhibited antimicrobial activity against VREF, with inhibition zones of 8.33 mm and 8.67 mm at concentrations of 50 g/disk and 100 g/disk, respectively. GIE also showed potential as an antioxidant and was able to inhibit and eradicate biofilms formed by VREF. However, further research is needed to fully understand the mechanisms and optimize the use of GIE for therapeutic applications. [Extracted from the article]

A study conducted at the University of Zimbabwe explored the genomic traits of infant-associated microbiota members, specifically Bifidobacterium and Enterococcus, in a Zimbabwean cohort. The researchers isolated bacterial strains from the gut of Zimbabwean infants and compared their genomic characteristics with strains from infants in North America, Europe, and other regions of Africa. The study found location-based clustering within taxonomic groups and identified species-specific variances in the potential of Bifidobacterium for metabolizing human milk oligosaccharides. The presence of antibiotic resistance genes in infant-associated microbes raises concerns for infection risk and probiotic development. This research contributes to the development of probiotic interventions tailored to the Zimbabwean population and provides insights into antimicrobial resistance in different regions. [Extracted from the article]

A recent report from the University College London (UCL) discusses the potential of bacteriocins, antimicrobial peptides naturally produced by bacteria, in fighting antibiotic-resistant bacteria. The researchers at UCL have developed a bacteriocin secretion platform that can express and secrete multiple bacteriocins from non-pathogenic Escherichia coli host strains. They have successfully created strains that show strong antimicrobial activity against Enterococcus faecalis and Enterococcus faecium. The researchers believe that this system has the potential to be used as a live biotherapeutic product for targeted killing of pathogenic bacteria. [Extracted from the article]

A recent preprint abstract discusses the rising prevalence of multidrug resistant (MDR) bacterial infections, particularly MDR enterococci, and the stagnant development of antibiotics to combat these infections. The abstract suggests that bacteriophage (phage) therapy, which uses lytic viruses to kill pathogenic bacteria, may be a potential therapeutic approach for MDR enterococci. The researchers used a CRISPR interference (CRISPRi) screen to identify a genetic locus involved in phage resistance in Enterococcus faecalis. They found that a putative serine recombinase followed by a Type IV restriction enzyme (TIV-RE) restricts the replication of phage phi47 in E. faecalis, and that phi47 evolves to overcome this restriction by acquiring a missense mutation in a TIV-RE inhibitor protein. The inhibitor, called type IV restriction inhibiting factor A (tifA), binds and inactivates diverse TIV-REs. This research provides insight into phage defense in drug-resistant E. faecalis and how phages evolve to overcome antiphage defense systems. [Extracted from the article]

University of Arkansas researchers conducted a study to determine if feeding pigs a water-soluble chlorophyllin product could affect the antibiotic resistance profiles of fecal bacteria. The study involved two trials and found that chlorophyllin supplementation did not have an adverse effect on the pigs' feed intake or weight gain. However, the presence of certain antibiotics in the pigs' diets was associated with higher populations of E. coli and enterococci in their feces. The researchers concluded that further research is needed to optimize chlorophyll administration for potential practical applications in the swine industry. [Extracted from the article]

A recent study published in the journal Nature has shed light on the role of the microbiome in acute graft-versus-host disease (aGVHD), a common complication of allogenic haematopoietic cell transplantation (allo-HCT). The study focused on the prevalence and implications of Enterococcus domination in allo-HCT patients and identified an intriguing bacteriophage-derived enzyme called endolysin that specifically targets Enterococcus faecalis. The endolysin exhibited potent antibacterial activity against E. faecalis and effectively lysed biofilms without affecting other intestinal bacteria species. The findings hold promise for future applications in preventing or treating aGVHD. [Extracted from the article]

A recent report from the University of Texas Dallas discusses the opportunistic pathogen Enterococcus faecium, which colonizes humans and animals, resists antibiotic treatment, and persists in clinical environments. The widespread use of antibiotics has led to the emergence of vancomycin-resistant E. faecium, causing hospital-acquired infections. The report explores the evolutionary history, environmental adaptation, colonization and dissemination mechanisms of E. faecium and vancomycin-resistant E. faecium. The findings provide insights for developing preventive and therapeutic approaches against vancomycin-resistant E. faecium and shed light on the emergence and endurance of antibiotic-resistant pathogens. [Extracted from the article]

Researchers from the Department of Pathogen Biology at Jilin University in China have isolated and characterized a lytic phage called phEc-ZZ2 that can effectively target and destroy Enterococcus faecium, a bacterium that causes infections, particularly in immunocompromised patients. The phage has a broad host range, stable pH, and exhibits rapid adsorption and a large burst size. These characteristics make phEc-ZZ2 a potential candidate for therapeutic or disinfectant use in controlling nosocomial infections caused by E. faecium. Further research on the interaction between Enterococcus phages and their hosts is warranted. [Extracted from the article]

A study conducted by researchers at Hamadan University of Medical Sciences explores the antimicrobial properties of copper oxide nanoparticles when combined with tissue conditioner used in complete prostheses. The study involved 126 tissue conditioner samples with varying concentrations of copper oxide nanoparticles, which were then incubated with different microorganisms. The results showed that the tissue conditioners containing copper oxide nanoparticles exhibited antimicrobial properties against Enterococcus faecalis, Pseudomonas aeruginosa, and Candida albicans. The researchers concluded that these nanoparticles could be a promising solution for improving the treatment of tissues supporting complete dentures. [Extracted from the article]

A study conducted by researchers at the Institute of Food Safety in Latvia highlights the prevalence of antimicrobial resistance (AMR) in Enterococcus bacteria, particularly vancomycin-resistant strains. The study analyzed 140 Enterococcus isolates collected from two hospitals in Latvia between 2021 and 2022. The findings revealed that the isolates exhibited resistance to multiple antimicrobial classes, with 25% of them showing resistance to vancomycin. The study emphasizes the need for effective infection control measures and continuous surveillance of vancomycin-resistant Enterococcus in Latvian hospitals to inform clinical decision-making and preventive strategies. [Extracted from the article]

Researchers from the Centro de Investigacion en Alimentacion y Desarrollo in Sonora, Mexico have found that lactic acid bacteria (LAB) isolated from the surface of jalapeno peppers can produce peptides called bacteriocins that have antagonistic activity against foodborne pathogens such as Listeria monocytogenes, Staphylococcus aureus, Escherichia coli O157:H7, and Salmonella Typhimurium. Out of 390 LAB strains evaluated, 60 produced bacteriocin-like inhibitory substances (BLIS) that retained their bioactivity even after heat treatment. Four of these BLIS exhibited broad-spectrum antagonistic activity against foodborne pathogens, making them a promising source of natural antimicrobials for ensuring food safety. [Extracted from the article]

Researchers from the University of Pisa in Italy have conducted a study on antibiotic-resistant bacteria in laboratory-reared mealworm larvae and their frass (excrement). The study found that antibiotic-resistant Enterobacteriaceae and enterococci were present in the larvae and frass samples. The resistance observed in the bacteria seemed to be intrinsic, except for some resistance in Shigella boydii. The researchers suggest further investigations to understand the role of edible insects in the spread of antibiotic resistance through the food chain. [Extracted from the article]

A preprint abstract from biorxiv.org discusses the rising prevalence of multidrug resistant (MDR) bacterial infections, particularly MDR enterococci, which are a common cause of hospital-acquired infections. The article suggests that bacteriophage (phage) therapy, which uses lytic viruses to kill pathogenic bacteria, could be a potential therapeutic approach for combating MDR enterococci. The study identifies a genetic locus involved in phage resistance in vancomycin-resistant Enterococcus faecalis and shows that phage phi47 can evolve to overcome this resistance by acquiring a missense mutation in a novel inhibitor protein. The findings contribute to our understanding of phage defense in drug-resistant E. faecalis and how phages can evolve to overcome antiphage defense systems. [Extracted from the article]

A preprint abstract from biorxiv.org discusses the potential use of bacteriophages in treating antibiotic-resistant infections, specifically enterococcus infections. The study found that there were synergistic interactions between multiple phages and antibiotics, including linezolid, ampicillin, and vancomycin. The combination of vancomycin and phages was effective in eradicating both vancomycin-resistant and vancomycin-susceptible isolates of Enterococcus faecium and Enterococcus faecalis. The research suggests that using phages could restore the effectiveness of vancomycin against resistant isolates, providing a promising strategy for treating Vancomycin Resistant Enterococcus infections. However, it is important to note that this preprint has not been peer-reviewed. [Extracted from the article]

Researchers from Wuhan University in China have published a new report on the mechanisms of Triton X-100 reducing the Ag+-resistance of Enterococcus faecalis (E. faecalis), a type of Gram-Positive Bacteria. The study aimed to investigate the antibacterial effect of Triton X-100 + Ag+ against induced Ag+-resistant E. faecalis (AREf). The researchers found that Triton X-100 could facilitate Ag+ to enter E. faecalis by changing the membrane structure and integrity, reducing the Ag+-resistance of the bacteria and enhancing the antibacterial effect. The study was supported by the National Natural Science Foundation of China. [Extracted from the article]

A study conducted at Wuhan University in China has found that Triton X-100, a chemical compound, can counteract antibiotic resistance in Enterococcus faecalis, a type of Gram-positive bacteria. The researchers conducted in vitro experiments to evaluate the antimicrobial activity of antibiotics in the presence of Triton X-100. They found that a low concentration of Triton X-100 improved the effectiveness of the antibiotics against antibiotic-resistant E. faecalis by increasing cell membrane permeability and reducing antibiotic resistance and pathogenicity. These findings could potentially contribute to the development of new disinfectants for root canals that can reduce antibiotic resistance. [Extracted from the article]

A recent report from the Free University of Brussels discusses the evaluation of an automated disk diffusion antimicrobial susceptibility testing (AST) system called Radian(R) In-Line Carousel. The study compared the results of Radian(R) with manual disk diffusion AST and found a high level of agreement between the two methods. The Radian(R) system was able to accurately detect bacterial growth and antibiotic interactions, reducing the time and potential for errors associated with manual testing. Additionally, the study confirmed the thermostability of antibiotic disks in the Radian(R) system for up to 4 days. This research provides valuable insights into improving AST methods and standardization in the field of microbiology. [Extracted from the article]

A recent study conducted at King Khalid University in Saudi Arabia analyzed the antimicrobial susceptibility patterns of Enterococcus species isolated from nosocomial infections in a Saudi Arabian tertiary care hospital over a ten-year period. The study found that vancomycin-resistant enterococci (VRE) posed a significant treatment challenge, accounting for 15.9% of isolates. The most common species identified was E. faecalis, while E. faecium had the highest percentage of VRE. VRE cases had a significantly higher mortality rate compared to vancomycin-sensitive enterococci (VSE). The study provides valuable insights into the characterization and antimicrobial susceptibility patterns of Enterococcus species in a hospital setting. [Extracted from the article]

A recent study from Madrid, Spain, explores the role of the gut microbiome in metabolism, the immune system, and the nervous system. The researchers investigated the bioelectrical profile of two bacterial species found in the gut microbiome, Escherichia coli and Enterococcus faecalis. They found distinct bioelectrical profiles for each species and observed that neural-type stimuli can induce changes in membrane potential without affecting bacterial growth. These findings have potential implications for modulating bacterial bioelectricity as a novel therapeutic target. [Extracted from the article]

Researchers from King Saud University in Riyadh, Saudi Arabia have conducted a study on the antibacterial and antibiofilm activities of selenium nanoparticles-antibiotic conjugates against multidrug-resistant bacteria, specifically Pseudomonas aeruginosa. The study found that the conjugation of selenium nanoparticles with antibiotics such as amikacin, levofloxacin, and piperacillin increased their antibacterial potency against resistant pathogens at a low concentration. The researchers suggest that these antibiotic-conjugated selenium nanoparticles have great potential for biomedical applications. The study has been peer-reviewed and published in the International Journal of Pharmaceutics. [Extracted from the article]

Researchers from Ilam University in Iran conducted a study comparing the antibacterial effects of Scrophularia Striata extract, sodium hypochlorite, and chlorhexidine on Enterococcus faecalis in tooth root canals. The study involved sixty extracted teeth infected with Enterococcus faecalis, which were divided into three groups: chlorhexidine 2%, sodium hypochlorite 2.5%, and Scrophularia striata extract (at a concentration obtained from MIC, 20%). The results showed that sodium hypochlorite had a bactericidal effect of 66.6%, chlorhexidine had a bactericidal effect of 55.5%, and Scrophularia striata extract had a bactericidal effect of 5.55%. The researchers concluded that the antibacterial effect of Scrophularia striata extract was significantly lower than chlorhexidine and sodium hypochlorite, but it could be considered as an alternative to synthetic therapeutic irrigants. [Extracted from the article]

A recent study conducted at Princess Nourah bint Abdulrahman University in Riyadh, Saudi Arabia, investigated the antimicrobial activity of tea tree oil (TTO) and its metal nanoparticles (NPs) against oral bacteria. The researchers found that TTO and zinc and iron nanoparticles had significant antibacterial efficacy against the tested oral microbes. However, TTO extract was more effective than the nanoparticles. The study also highlighted the potential antagonistic effects of combining TTO with antibiotics and common mouthwashes, which could impact therapeutic efficacy and increase the risk of microbial resistance. The findings suggest that TTO phytochemicals could be further explored for the development of antimicrobial nanoparticles. [Extracted from the article]

A recent report from Shri Dharmasthala Manjunatheshwara University in Karnataka, India, highlights the growing challenge of bacterial infections caused by ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp.). These pathogens have robust antibiotic resistance mechanisms, making them difficult to treat with traditional antimicrobial therapies. The study emphasizes the need for a better understanding of the mechanisms behind antibacterial resistance in ESKAPE bacteria in order to develop effective interventions and preventive measures. The research focuses on the patho-mechanisms of ESKAPE bacteria and the genes involved in multi-drug resistance. [Extracted from the article]

According to a preprint abstract, researchers have found that the amino acid arginine has an impact on the growth and behavior of Enterococcus faecalis, a bacterium found in the human gastrointestinal tract. The study showed that arginine decreases biofilm production and causes changes in gene expression related to metabolism and polysaccharide synthesis. Additionally, growth in arginine increases aggregation of E. faecalis and reduces susceptibility to certain antibiotics. This research provides insight into how the presence of arginine in biological environments affects the physiology and virulence of E. faecalis and surrounding microbes. Please note that this study has not yet undergone peer review. [Extracted from the article]

A recent study conducted by researchers at Kurdistan University of Medical Sciences in Iran explored the antibacterial effects of farnesol and chitosan on Enterococcus faecalis biofilm. The study found that both farnesol and chitosan, either alone or in combination, were effective in destroying the living cells of Enterococcus faecalis biofilm. The combination of farnesol and chitosan had the greatest effect on destroying biofilm bacteria. The researchers recommend the use of this combination for irrigation of the root canal, particularly in the re-treatment of the root and teeth with periapical lesions. [Extracted from the article]

A recent report from Novosibirsk State Technical University in Russia discusses the use of probiotic bacteria to restore the gut microbiota in mice with impaired mucosal layers. The researchers found that the recovery time and the type of probiotic bacteria used affected the number of Enterococcus faecalis, a type of bacteria. Interestingly, the treatment with Lactobacillus johnsonii caused a decrease in the amount of E. faecalis, and both L. johnsonii and E. faecalis treatment eliminated protozoan overgrowth caused by antibiotic administration. This research suggests that targeted antibiotic therapy and probiotic supplementation may be effective strategies for treating inflammatory bowel disease. [Extracted from the article]

A retrospective study conducted at the Children's Hospital of Fudan University in China explored the uropathogen and antibiotic resistance in children with urinary tract infections (UTIs). The study included 840 children, with Escherichia coli being the most prevalent isolate, followed by Enterococcus faecium and Enterococcus faecalis. These organisms showed high resistance to commonly used antibiotics, and multiple drug resistance (MDR) was observed in a significant proportion of cases. The study also found a relatively high prevalence of MDR and a low proportion of Extended Spectrum b-Lactamase (ESbL)-producing organisms. [Extracted from the article]

A recent study conducted at the Medical College of Wisconsin examined the role of colonic macrophages in facilitating Enterococcus faecalis infections in mice. The researchers found that depletion of colonic phagocytes resulted in a reduction of E. faecalis dissemination to the gut-draining lymph nodes. They also discovered that trafficking of monocyte-derived macrophages contributed to E. faecalis dissemination in a manner that was not reliant on the conventional receptor involved in lymphatic migration. The study suggests that modulation of macrophage trafficking could be a novel approach for preventing or treating opportunistic infections caused by E. faecalis. [Extracted from the article]

A recent report from Ghent University in Belgium provides new insights into the genetic landscape of antimicrobial resistance genes in Enterococcus cecorum broiler isolates. The study found that several antimicrobial resistance genes were detected in the isolates, including those linked to resistance against vancomycin, tetracycline, lincomycin, spectinomycin, and tylosin. The research also identified point mutations in isolates with non-wild-type phenotypes for enrofloxacin and ampicillin/ceftiofur. This study contributes to our understanding of antimicrobial resistance in Enterococcus cecorum and its association with genetic factors. [Extracted from the article]

A study conducted by researchers at Southwest University in China has found that a bacteriocin called paracin wx7 shows selective inhibition against vancomycin-resistant Enterococcus faecalis (E. faecalis), a bacteria that poses a health risk in fresh-cut vegetables. The bacteriocin demonstrated instant bactericidal effects and damaged the membrane integrity of E. faecalis, resulting in cell deformation. Additionally, paracin wx7 induced the production of reactive oxygen species in the cytoplasm of the bacteria. This research provides insights into the potential use of paracin wx7 as a biopreservative in food to combat vancomycin-resistant E. faecalis. [Extracted from the article]

A preprint abstract from biorxiv.org discusses the effectiveness of antibiotics against intracellular Staphylococcus aureus infections in osteocytes. The study found that only rifampicin, levofloxacin, and linezolid significantly reduced the number of intracellular bacteria in an acute infection model. However, no treatment was able to reduce the quantity of bacterial mRNA or prevent non-culturable bacteria from returning to a culturable state. These findings suggest that new therapeutic approaches are needed to effectively treat intracellular S. aureus infections in osteocytes. The preprint has not yet undergone peer review. [Extracted from the article]

A recent study conducted by the Slovak Academy of Sciences has found that certain strains of beneficial bacteria, known as probiotics, have the potential to act as antiparasitic agents against Trichinella spiralis, a parasitic worm. The study tested the effects of two bacteriocins, Enterocin M and Durancin-like, produced by Enterococcus faecium CCM8558 and Enterococcus durans ED26E/7, respectively, on mice infected with Trichinella spiralis. The results showed that these bacteriocins reduced the number of adult worms in the intestine, suppressed the reproductive capacity of the parasite, and decreased the number of muscle larvae. The study suggests that these probiotics could be a new therapeutic strategy for treating trichinellosis. [Extracted from the article]

A recent study conducted at Lucian Blaga University of Sibiu in Romania has revealed new findings on nosocomial infections, which are infections acquired in hospitals. The study focused on the ESKAPE group of bacteria, which are known for their high resistance to antibiotics and are a major cause of nosocomial infections worldwide. The researchers found that the most common bacteria isolated from patients in the Intensive Care Unit were Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa. The rise of antibiotic resistance in these bacteria raises concerns about limited treatment options. [Extracted from the article]

Researchers from Durban University of Technology in South Africa have published a report on antimicrobials, focusing on the ESKAPE pathogens and their associated quorum sensing systems (QSSs). These pathogens, including Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp., are classified as priority 1 antimicrobial resistance (AMR) pathogens. The report highlights the need for new targets in antimicrobial development to combat the increasing rates of AMR and improve public health. The researchers also discuss the potential of computational modeling technologies in drug design efforts. [Extracted from the article]

A recent study conducted at the University of Karachi examined the antibiotic resistance and susceptibility profile of Enterococcus species isolated from blood and urine samples. Enterococcus is a type of Gram-positive bacteria commonly found in the human intestine and can act as probiotics. However, they can also cause infections, especially in healthcare settings. The study found that Enterococcus species exhibited high resistance to the antibiotic levofloxacin, while they were sensitive to linezolid. Additionally, all organisms were able to form biofilms, which contribute to antibiotic resistance. The researchers concluded that antibiotic resistance in Enterococcus is a growing concern globally, leading to an increase in nosocomial infections. [Extracted from the article]